Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

242 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Cooperation between Clinics and Hospitals Using a Critical Path for G-CSF Prophylaxis in Cancer Chemotherapy].
Takahashi T, Takahashi F, Okada Y, Ito S, Ugata N, Shimasaki Y, Mochida H, Matsuda S, Okada T, Kumanomidou S, Jo Y, Adachi K, Ikejiri F, Onishi C, Kawakami K, Moriyama I, Inoue M, Miyake T, Suzuki R, Suzumiya J. Takahashi T, et al. Among authors: moriyama i. Gan To Kagaku Ryoho. 2019 Mar;46(3):457-461. Gan To Kagaku Ryoho. 2019. PMID: 30914584 Japanese.
[Diagnosis and treatment of peripheral T-cell lymphoma].
Suzumiya J, Moriyama I, Kawakami K. Suzumiya J, et al. Among authors: moriyama i. Nihon Rinsho. 2012 Apr;70 Suppl 2:519-24. Nihon Rinsho. 2012. PMID: 23134009 Japanese. No abstract available.
A retrospective study of R-CHOP/CHOP therapy-induced nausea and vomiting in non-Hodgkin's lymphoma patients: a comparison of intravenous and oral 5-HT3 receptor antagonists.
Takahashi T, Kumanomidou S, Takami S, Okada T, Adachi K, Jo Y, Ikejiri F, Onishi C, Kawakami K, Miyake T, Inoue M, Moriyama I, Suzuki R, Suzumiya J. Takahashi T, et al. Among authors: moriyama i. Int J Hematol. 2016 Sep;104(3):378-83. doi: 10.1007/s12185-016-2041-z. Epub 2016 Jun 16. Int J Hematol. 2016. PMID: 27312042
Differential gene expression analysis of dasatinib-induced colitis in a patient with chronic myeloid leukemia followed for 3 years: a case report.
Oshima N, Mishima Y, Shibagaki K, Kawashima K, Ishimura N, Ikejiri F, Onishi C, Okada T, Inoue M, Moriyama I, Suzumiya J, Kinoshita Y, Ishihara S. Oshima N, et al. Among authors: moriyama i. BMC Gastroenterol. 2021 Jan 6;21(1):19. doi: 10.1186/s12876-020-01584-6. BMC Gastroenterol. 2021. PMID: 33407162 Free PMC article.
[A phase II study of Futraful suppository in head and neck cancer].
Ohyama M, Matsumura M, Katsuta K, Nobori T, Furuta S, Matsunaga S, Uchizono A, Hanada T, Moriyama I, Kamachi S, et al. Ohyama M, et al. Among authors: moriyama i. Gan To Kagaku Ryoho. 1988 Jul;15(7):2093-100. Gan To Kagaku Ryoho. 1988. PMID: 3134860 Japanese.
Evaluation of modified crystal violet chromoendoscopy procedure using new mucosal pit pattern classification for detection of Barrett's dysplastic lesions.
Yuki T, Amano Y, Kushiyama Y, Takahashi Y, Ose T, Moriyama I, Fukuhara H, Ishimura N, Koshino K, Furuta K, Ishihara S, Adachi K, Kinoshita Y. Yuki T, et al. Among authors: moriyama i. Dig Liver Dis. 2006 May;38(5):296-300. doi: 10.1016/j.dld.2006.01.028. Epub 2006 Mar 20. Dig Liver Dis. 2006. PMID: 16542886 Clinical Trial.
A phase II study of FOLFOXIRI plus bevacizumab as initial chemotherapy for patients with untreated metastatic colorectal cancer: TRICC1414 (BeTRI).
Shinozaki K, Yamada T, Nasu J, Matsumoto T, Yuasa Y, Shiraishi T, Nagano H, Moriyama I, Fujiwara T, Miguchi M, Yoshida R, Nozaka K, Tanioka H, Nagasaka T, Kurisu Y, Kobayashi M, Tsuchihashi K, Inukai M, Kikuchi T, Nishina T. Shinozaki K, et al. Among authors: moriyama i. Int J Clin Oncol. 2021 Feb;26(2):399-408. doi: 10.1007/s10147-020-01811-w. Epub 2020 Oct 23. Int J Clin Oncol. 2021. PMID: 33097971 Free PMC article. Clinical Trial.
242 results